Waite R P, Pang C C, Walker M J
Department of Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
J Cardiovasc Pharmacol. 1988;12(5):499-504. doi: 10.1097/00005344-198811000-00001.
The effects of three calcium antagonists (verapamil, nifedipine, and flunarizine) on mean arterial pressure (MAP), heart rate (HR), and mean circulatory filling pressure (MCFP), an index of total body venous tone, were investigated in the conscious, unrestrained rat. Infusions of all three drugs caused a dose-dependent decrease in MAP and an increase in MCFP, compared with the corresponding values in control rats. HR was decreased by verapamil and flunarizine and slightly increased by nifedipine. Further experiments investigated whether the increase in MCFP by verapamil was indirectly caused by reflex activation of the sympathetic nervous system. Rats were pretreated with a continuous infusion of hexamethonium prior to the infusion of verapamil. After treatment with hexamethonium, verapamil did not increase the MCFP. In fact, the highest dose of verapamil significantly decreased MCFP. The results suggest that calcium antagonists have greater dilator effects in arterioles compared to veins. It appears that any direct venodilator effects of verapamil in conscious rats are masked due to reflex activation of the autonomic nervous system.
在清醒、不受束缚的大鼠中,研究了三种钙拮抗剂(维拉帕米、硝苯地平和氟桂利嗪)对平均动脉压(MAP)、心率(HR)以及平均循环充盈压(MCFP,全身静脉张力指标)的影响。与对照大鼠的相应值相比,所有三种药物的输注均导致MAP呈剂量依赖性降低且MCFP升高。维拉帕米和氟桂利嗪使HR降低,硝苯地平使HR略有升高。进一步的实验研究了维拉帕米引起的MCFP升高是否由交感神经系统的反射性激活间接导致。在输注维拉帕米之前,大鼠先接受六甲铵的持续输注预处理。用六甲铵处理后,维拉帕米未使MCFP升高。实际上,最高剂量的维拉帕米显著降低了MCFP。结果表明,与静脉相比,钙拮抗剂对小动脉具有更强的扩张作用。维拉帕米在清醒大鼠中的任何直接静脉扩张作用似乎都因自主神经系统的反射性激活而被掩盖。